Camex Q4 FY26 Results: Sales up 11%, profit jumps

Key update from Camex’s latest results

Camex has reported a stronger set of standalone numbers for the quarter ended March 2026, with revenue growth and a sharp year-on-year rise in profitability. Net sales for the March 2026 quarter came in at Rs 41.35 crore, compared with Rs 37.21 crore in the March 2025 quarter. The company also reported a large jump in quarterly net profit to Rs 1.81 crore in March 2026 from Rs 0.15 crore a year earlier. EBITDA for the quarter increased to Rs 2.62 crore from Rs 1.06 crore. EPS for the March 2026 quarter rose to Rs 1.80 versus Rs 0.12 in March 2025. The current share price mentioned alongside the update is Rs 41.7.

March 2026 quarter: revenue, costs, and operating profit

In the quarterly summary (all figures in crore), Camex reported net sales of Rs 41.35 crore for March 2026. Total expenditure for the same quarter was Rs 38.86 crore. Operating profit was Rs 2.49 crore in March 2026, improving from Rs 2.06 crore in March 2025 and Rs 1.41 crore in December 2025. Other income for March 2026 was Rs 0.12 crore, while interest cost was Rs 0.21 crore. These reported line items indicate that the improvement in profit was supported by higher sales and higher operating profit compared with the year-ago quarter.

Five-quarter trend: net sales and operating profit

The quarterly table shows a relatively stable revenue run-rate through FY26, followed by a pickup in the March 2026 quarter. Net sales were Rs 37.21 crore in March 2025, Rs 34.37 crore in June 2025, Rs 37.22 crore in September 2025, and Rs 36.62 crore in December 2025. The March 2026 quarter then increased to Rs 41.35 crore. Operating profit across these quarters was Rs 2.06 crore (Mar 2025), Rs 1.41 crore (Jun 2025), Rs 0.27 crore (Sep 2025), Rs 1.41 crore (Dec 2025), and Rs 2.49 crore (Mar 2026). The September 2025 quarter stands out for a low operating profit of Rs 0.27 crore, followed by a recovery into December 2025 and March 2026.

Detailed quarterly snapshot: March 2026 vs December 2025 vs March 2025

In the detailed quarterly disclosure, Camex reported total income from operations of Rs 41.35 crore in March 2026, Rs 36.62 crore in December 2025, and Rs 37.21 crore in March 2025. Net profit for the period was Rs 1.81 crore in March 2026, compared with Rs 0.82 crore in December 2025 and Rs 0.15 crore in March 2025. Profit before tax was Rs 2.46 crore in March 2026, Rs 1.05 crore in December 2025, and Rs 0.46 crore in March 2025. Tax for March 2026 was Rs 0.65 crore, compared with Rs 0.23 crore in December 2025 and Rs 0.31 crore in March 2025. The company reported exceptional items of Rs 0.24 crore in March 2026, while March 2025 showed -0.01 crore.

EBITDA and EPS: what changed year-on-year

Camex’s reported EBITDA in March 2026 was Rs 2.62 crore, up from Rs 1.06 crore in March 2025. This was presented as a 147.17% increase year-on-year. The reported quarterly net profit of Rs 1.81 crore in March 2026 was shown as up 1133.13% from Rs 0.15 crore in March 2025. EPS for the March 2026 quarter increased to Rs 1.80 from Rs 0.12 in March 2025. These movements indicate that profitability improved at a faster pace than revenue in the March 2026 quarter.

Full-year picture: FY26 versus earlier years

In the annual profit and loss table (all figures in crore), Camex reported net sales of Rs 149.56 crore for the year ended March 2026, compared with Rs 133.65 crore in March 2025 and Rs 141.81 crore in March 2024. Total expenditure was Rs 143.98 crore in FY26 versus Rs 129.71 crore in FY25. Operating profit stood at Rs 5.58 crore in FY26, up from Rs 3.94 crore in FY25 and Rs 4.64 crore in FY24. Other income reduced to Rs 0.36 crore in FY26 from Rs 0.84 crore in FY25. Interest cost was Rs 1.09 crore in FY26 compared with Rs 1.33 crore in FY25 and Rs 0.76 crore in FY24.

Longer-term financial snapshot (FY19 to FY23)

A separate multi-year snapshot lists income and expenses for FY19 to FY23 in crore. Income is shown as Rs 147 crore (FY19), Rs 132 crore (FY20), Rs 151 crore (FY21), Rs 180 crore (FY22), and Rs 148 crore (FY23). Expenses are shown as Rs 143 crore (FY19), Rs 131 crore (FY20), Rs 149 crore (FY21), Rs 179 crore (FY22), and Rs 148 crore (FY23). Net profit is listed as Rs 3.69 crore (FY19), Rs 1.25 crore (FY20), Rs 1.36 crore (FY21), Rs 3.18 crore (FY22), and -Rs 0.32 crore (FY23). Basic EPS (continuing) is shown as Rs 3.61 (FY19), Rs 1.21 (FY20), Rs 1.37 (FY21), Rs 3.19 (FY22), and -Rs 0.3 (FY23).

Corporate disclosure: resubmission and capital change

Alongside financial reporting, the company disclosed that it re-submitted its unaudited Q3 and 9M 2025 results with minor typographical corrections. The disclosure stated there were no material changes. Camex also noted that its authorised share capital was increased following shareholders’ approval. These updates matter for investors primarily because they relate to the reliability of disclosed financial information and the company’s capital structure disclosures.

Key numbers at a glance

Market context and what investors tracked

The update includes a stated current share price of Rs 41.7. For market participants, the most directly comparable operating metrics in this release are the March 2026 quarter versus the March 2025 quarter, where both revenue and profit improved. Investors also tend to track whether operating profit sustains after quarters like September 2025, when operating profit was reported at Rs 0.27 crore. The annual FY26 figures show net sales of Rs 149.56 crore and operating profit of Rs 5.58 crore, providing a broader context beyond a single quarter. Disclosures on resubmission and authorised share capital are typically read alongside the numbers because they relate to reporting and corporate actions.

Conclusion

Camex’s standalone March 2026 quarter showed net sales of Rs 41.35 crore and net profit of Rs 1.81 crore, with EPS at Rs 1.80, compared with much lower profit and EPS in the March 2025 quarter. On the annual table, FY26 net sales were Rs 149.56 crore and operating profit was Rs 5.58 crore. The company also disclosed a resubmission of unaudited Q3 and 9M 2025 results with minor typographical corrections and no material changes, and an increase in authorised share capital after shareholder approval. The next items investors typically watch are subsequent quarterly disclosures and any further details the company provides in its results announcements.